BIOTECH ACQUISITION COMPANY - *W EXP 11/30/202 (BIOTW)

CUSIP: G1125A116

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / *W EXP 11/30/202
Total 13F shares
3,452,362
Share change
+3,452,362
Total reported value
$2,077,000
Price per share
$0.60
Number of holders
20
Value change
+$2,077,000
Number of buys
20

Quarterly Holders Quick Answers

What is CUSIP G1125A116?
CUSIP G1125A116 identifies BIOTW - BIOTECH ACQUISITION COMPANY - *W EXP 11/30/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BIOTECH ACQUISITION COMPANY - *W EXP 11/30/202 (BIOTW) as of Q1 2021

As of 31 Mar 2021, BIOTECH ACQUISITION COMPANY - *W EXP 11/30/202 (BIOTW) was held by 20 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,452,362 shares. The largest 10 holders included Corbin Capital Partners, L.P., CITADEL ADVISORS LLC, Polar Asset Management Partners Inc., MMCAP International Inc. SPC, Atalaya Capital Management LP, KINGSTOWN CAPITAL MANAGEMENT L.P., Blackstone Group Inc., MANGROVE PARTNERS, FIR TREE CAPITAL MANAGEMENT LP, and Sculptor Capital LP. This page lists 20 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.